カテゴリ： GlobalData, 医療/バイオ

菌血症治療薬の世界市場：治験レビュー

◆英語タイトル：Bacteremia Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0050
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：701
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥275,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥550,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥825,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Bacteremia Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Bacteremia Global Clinical Trials Review, H2, 2019″ provides an overview of Bacteremia clinical trials scenario. This report provides top line data relating to the clinical trials on Bacteremia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacteremia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacteremia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Bacteremia Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Bacteremia 30
Nov 05, 2019: ContraFect to present at the World Anti-Microbial Resistance Congress 2019 30
Clinical Trial Profile Snapshots 30
Appendix 707
Abbreviations 707
Definitions 707
Research Methodology 708
Secondary Research 708
About GlobalData 709
Contact Us 709
Source 710

List of Tables
Bacteremia Therapeutics, Global, Clinical Trials by Region, 2019* 7
Bacteremia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Bacteremia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Bacteremia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Bacteremia Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Bacteremia Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Bacteremia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Bacteremia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Bacteremia to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 16
Bacteremia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Bacteremia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Bacteremia to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 19
Bacteremia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Bacteremia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Bacteremia Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Bacteremia Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Bacteremia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Bacteremia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Bacteremia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 25
Bacteremia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 26
Bacteremia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Bacteremia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Bacteremia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

List of Figures
Bacteremia Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Bacteremia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Bacteremia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 9
Bacteremia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 10
Bacteremia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 11
Bacteremia Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 12
Bacteremia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 13
Bacteremia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 14
Proportion of Bacteremia to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 15
Bacteremia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 16
Bacteremia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 17
Proportion of Bacteremia to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 18
Bacteremia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 19
Bacteremia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 20
Bacteremia Therapeutics, Global, Clinical Trials by Phase (%), 2019* 21
Bacteremia Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 22
Bacteremia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 23
Bacteremia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 24
Bacteremia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 25
Bacteremia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 26
Bacteremia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 27
Bacteremia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 28
Bacteremia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 29
GlobalData Methodology 708

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[菌血症治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 細菌性膣炎治療薬の世界市場：治験レビュー
    GDT20FB0018 / GlobalData / 2019年9月 / ...Bacterial Vaginosis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bacterial Vaginosis Global Clinical Trials Review, H2, 2019" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
  2. ヘリコバクターピロリ感染治療薬の世界市場：治験レビュー
    GDT20FB0110 / GlobalData / 2020年1月 / ...Helicobacter pylori Infections Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Helicobacter pylori Infections Global Clinical Trials Review, H1, 2020" provides an overview of Helicobacter pylori Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Helicobacter pylori Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  3. 腎盂腎炎治療薬の世界市場：治験レビュー
    GDT20FB0035 / GlobalData / 2019年12月 / ...Pyelonephritis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2019" provides an overview of Pyelonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Pyelonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  4. 足白癬治療薬の世界市場：治験レビュー
    GDT20FB0092 / GlobalData / 2020年1月 / ...Tinea Pedis (Athlete Foot) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Tinea Pedis (Athlete Foot) Global Clinical Trials Review, H1, 2020" provides an overview of Tinea Pedis (Athlete Foot) Clinical trials scenario. This report provides top line data relating to the clinical trials on Tinea Pedis (Athlete Foot). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
  5. サイトメガロウイルス（HHV-5）感染治療薬の世界市場：治験レビュー
    GDT20FB0094 / GlobalData / 2020年1月 / ...Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2020" provides an overview of Cytomegalovirus (HHV-5) Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  6. ヒトパピローマウイルス感染治療薬の世界市場：治験レビュー
    GDT20FB0097 / GlobalData / 2020年1月 / ...Human Papillomavirus Infections Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Human Papillomavirus Infections Global Clinical Trials Review, H1, 2020 provides an overview of Human Papillomavirus Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Human Papillomavirus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  7. 敗血症治療薬の世界市場：治験レビュー
    GDT20FB0068 / GlobalData / 2019年12月 / ...Sepsis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, H2, 2019" provides an overview of Sepsis clinical trials scenario. This report provides top line data relating to the clinical trials on Sepsis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  8. 高脂血症治療薬の世界市場：治験レビュー
    GDT20FB0099 / GlobalData / 2020年1月 / ...Hyperlipidemia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H1, 2020" provides an overview of Hyperlipidemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  9. リーシュマニア症（カラアザール）治療薬の世界市場：治験レビュー
    GDT20FB0046 / GlobalData / 2019年12月 / ...Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2019" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  10. 開放隅角緑内障治療薬の世界市場：治験レビュー
    GDT20FB0115 / GlobalData / 2020年1月 / ...Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020" provides an overview of Open-Angle Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆